NHG-Standaard Fractuurpreventie (tweede herziening)

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Huisarts En Wetenschap

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Five Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the First Two Years of the FREEDOM Extension

  2012cited by this paper
• Incidence and demography of femur fractures with and without atypical features

  2012cited by this paper
• Adverse events from calcium supplementation: Relationship to errors in myocardial infarction self‐reporting in randomized controlled trials of calcium supplementation

  2012cited by this paper
• Height loss predicts subsequent hip fracture in men and women of the Framingham Study

  2012cited by this paper
• Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures.

  2012cited by this paper
• A European multicenter comparison of quantitative ultrasound measurement variables: The OPUS study

  2012cited by this paper
• Height loss in older women: Risk of hip fracture and mortality independent of vertebral fractures

  2012cited by this paper
• Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation

  2012cited by this paper
• Snelle inschatting van de kans op herhaald vallen bij ouderen

  2011cited by this paper
• "'Timed up and go' test and bone mineral density measurement for fracture prediction.

  2011cited by this paper
• Absolute Fracture-Risk Prediction by a Combination of Calcaneal Quantitative Ultrasound and Bone Mineral Density

  2011cited by this paper
• Effects of denosumab on fracture and bone mineral density by level of kidney function

  2011cited by this paper
• Denosumab and bisphosphonates: different mechanisms of action and effects.

  2011cited by this paper
• Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.

  2011cited by this paper
• Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw

  2011cited by this paper
• Screening for impaired visual acuity in older adults.

  2011cited by this paper
• Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?

  2011cited by this paper
• Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.

  2011cited by this paper
• The Role of Falls in Fracture Prediction

  2011cited by this paper
• Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer

  2011cited by this paper
• Effect of denosumab on bone mineral density and biochemical markers of bone turnover: six-year results of a phase 2 clinical trial.

  2011cited by this paper
• Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

  2011cited by this paper
• Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.

  2011cited by this paper
• Primary Care–Relevant Interventions to Prevent Falling in Older Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force

  2010cited by this paper
• Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort

  2010cited by this paper
• Long-term use of bisphosphonates in osteoporosis.

  2010cited by this paper
• Using clinical risk factors and bone mineral density to determine who among patients undergoing bone densitometry should have vertebral fracture assessment

  2010cited by this paper
• Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands

  2010cited by this paper
• Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

  2010cited by this paper
• Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

  2010cited by this paper
• Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long‐term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long‐term extension (FLEX)

  2010cited by this paper
• Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate

  2010cited by this paper
• Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial.

  2010cited by this paper
• Sunlight exposure or vitamin D supplementation for vitamin D-deficient non-western immigrants: a randomized clinical trial

  2010cited by this paper
• Prevention of falls and fall-related injuries in older people

  2009cited by this paper
• A Simple Risk Score for the Assessment of Absolute Fracture Risk in General Practice Based on Two Longitudinal Studies

  2009cited by this paper
• Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

  2009cited by this paper
• Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data

  2009cited by this paper
• Fall risk: the clinical relevance of falls and how to integrate fall risk with fracture risk.

  2009cited by this paper
• Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study

  2009cited by this paper
• Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

  2009cited by this paper
• The effect of including quantitative heel ultrasound in models for estimation of 10-year absolute risk of fracture.

  2009cited by this paper
• Activation of β‐Catenin Signaling in Articular Chondrocytes Leads to Osteoarthritis‐Like Phenotype in Adult β‐Catenin Conditional Activation Mice

  2009cited by this paper
• Vitamin D: what is an adequate vitamin D level and how much supplementation is necessary?

  2009cited by this paper
• Hip Fracture Patients at Risk of Second Hip Fracture: A Nationwide Population‐Based Cohort Study of 169,145 Cases During 1977–2001

  2009cited by this paper
• Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry.

  2009cited by this paper
• Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.

  2009cited by this paper
• Bisphosphonate Associated Osteonecrosis of the Jaw

  2009cited by this paper
• Screening Older Adults for Impaired Visual Acuity: A Review of the Evidence for the U.S. Preventive Services Task Force

  2009cited by this paper
• Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

  2008cited by this paper
• Prospective evaluation of risk of vertebral fractures using quantitative ultrasound measurements and bone mineral density in a population-based sample of postmenopausal women: results of the Basel Osteoporosis Study

  2008cited by this paper
• Lack of Effectiveness of a Multidisciplinary Fall‐Prevention Program in Elderly People at Risk: A Randomized, Controlled Trial

  2008cited by this paper
• Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents: reply to comment by Vieth

  2008cited by this paper
• Systematic review of accuracy of screening instruments for predicting fall risk among independently living older adults.

  2008cited by this paper
• Bone Mineral Density Changes during the Menopause Transition in a Multiethnic Cohort of Women

  2008cited by this paper
• Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women

  2008cited by this paper
• Bone and fall-related fracture risks in women and men with a recent clinical fracture.

  2008cited by this paper
• Development of the Falls Risk for Older People in the Community (FROP-Com) screening tool.

  2008cited by this paper
• Multifactorial Fall‐Prevention Strategies: Time to Retreat or Advance

  2008cited by this paper
• Clinical subsequent fractures cluster in time after first fractures

  2008cited by this paper
• Naar een toereikende inname van vitamine D

  2008cited by this paper
• Bone mineral density changes during the menopause transition in a multiethnic cohort of women.

  2008cited by this paper
• Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

  2007cited by this paper
• Vertebral fracture assessment in patients presenting with incident nonvertebral fractures

  2007cited by this paper
• Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials.

  2007cited by this paper
• Risk of subsequent fracture after low-trauma fracture in men and women.

  2007cited by this paper
• Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial.

  2007cited by this paper
• Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study

  2007cited by this paper
• Improving Vision to Prevent Falls in Frail Older People: A Randomized Trial

  2007cited by this paper
• Zoledronic Acid in Reducing Clinical Fracture and Mortality after Hip Fracture.

  2007cited by this paper
• Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials.

  2007cited by this paper
• Measured Height Loss Predicts Fractures in Middle‐Aged and Older Men and Women: The EPIC‐Norfolk Prospective Population Study

  2007cited by this paper
• Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

  2007cited by this paper
• Multifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis

  2007cited by this paper
• The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.

  2007cited by this paper
• Zoledronic acid and clinical fractures and mortality after hip fracture.

  2007cited by this paper
• The population burden of fractures originates in women with osteopenia, not osteoporosis

  2006cited by this paper
• Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review

  2006cited by this paper
• Strontium Ranelate Reduces the Risk of Vertebral Fractures in Patients With Osteopenia

  2006cited by this paper
• Impact of Recent Fracture on Health‐Related Quality of Life in Postmenopausal Women

  2006cited by this paper
• Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women.

  2005cited by this paper
• Quality of life in patients with osteoporosis

  2005cited by this paper
• Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures

  2005cited by this paper
• Risk of new clinical fractures within 2 years following a fracture

  2005cited by this paper
• Alcohol intake as a risk factor for fracture

  2005cited by this paper
• Increased falling as a risk factor for fracture among older women: the study of osteoporotic fractures.

  2005cited by this paper
• A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids.

  2005cited by this paper
• Body mass index as a predictor of fracture risk: A meta-analysis

  2005cited by this paper
• Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials.

  2005cited by this paper
• Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial.

  2005cited by this paper
• A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis

  2005cited by this paper
• Smoking and fracture risk: a meta-analysis

  2005cited by this paper
• Asymptomatic Vertebral Deformity as a Major Risk Factor for Subsequent Fractures and Mortality: A Long‐Term Prospective Study

  2005cited by this paper
• Bone mineral density thresholds for pharmacological intervention to prevent fractures.

  2004cited by this paper
• Which circulating level of 25-hydroxyvitamin D is appropriate?

  2004cited by this paper
• Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis

  2004cited by this paper
• A family history of fracture and fracture risk: a meta-analysis.

  2004cited by this paper
• Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study.

  2004cited by this paper
• Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long‐Term Extension

  2004cited by this paper
• Risk Factors for Incident Vertebral Fractures in Men and Women: The Rotterdam Study

  2004cited by this paper

• Screening for high fracture risk

  2020cites this paper
• Fractuurpreventie met denosumab

  2019cites this paper
• Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis

  2019cites this paper
• The Effect of a Screening and Treatment Program for the Prevention of Fractures in Older Women: A Randomized Pragmatic Trial

  2019cites this paper
• Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

  2017cites this paper
• Bisfosfonaten tegen osteoporose door glucocorticosteroïden

  2017cites this paper
• 37 Ribs-on-pelvissyndroom

  2016cites this paper
• Richtlijn Osteoporose en fractuurpreventie

  2015cites this paper
• Nutrition, Nutritional State and Related Conditions in Older Adults with Intellectual Disabilities

  2014cites this paper
• Zin en onzin van kalk en vitamine D

  2014cites this paper
• Bone quality in older adults with intellectual disabilities.

  2014influential citation
• Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication

  2014cites this paper